Cargando…
Applying C. elegans to the Industrial Drug Discovery Process to Slow Aging
The increase in our molecular understanding of the biology of aging, coupled with a recent surge in investment, has led to the formation of several companies developing pharmaceuticals to slow aging. Research using the tiny nematode worm Caenorhabditis elegans was the first to show that mutations in...
Autores principales: | Weinkove, David, Zavagno, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261450/ https://www.ncbi.nlm.nih.gov/pubmed/35821999 http://dx.doi.org/10.3389/fragi.2021.740582 |
Ejemplares similares
-
Insights Into the Links Between Proteostasis and Aging From C. elegans
por: Zhang, William Hongyu, et al.
Publicado: (2022) -
Recent clinical trials with stem cells to slow or reverse normal aging processes
por: Garay, Ricardo P.
Publicado: (2023) -
The C. elegans Observatory: High-throughput exploration of behavioral aging
por: Kerr, Rex A., et al.
Publicado: (2022) -
C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration
por: Naranjo-Galindo, Francisco José, et al.
Publicado: (2022) -
Age-dependent accumulation of tau aggregation in Caenorhabditis elegans
por: Aquino Nunez, Wendy, et al.
Publicado: (2022)